EUVIMEDEUVIMED entdecken
Open Access

PET/MRI for neuroendocrine tumors: a match made in heaven or just another hype?

Ali Pirasteh, Christopher Riedl, Marius Erik Mayerhoefer, Romina Grazia Giancipoli, Steven Mark Larson, Lisa Bodei

Clinical and Translational Imaging · 2019-12 · 7 (6) · 405-413

DOI: 10.1007/s40336-019-00344-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Imaging, online erschienen am 20.09.2019. Verfasst von Ali Pirasteh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Wisconsin-Madison, 600 Highland Ave, E1/382C, Madison, WI 53792. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate the current literature on technical feasibility and diagnostic value of PET/MRI in management of patients with neuroendocrine tumors (NETs). METHODS: A systematic literature search of the PubMed/MEDLINE database identified studies that evaluated the role of simultaneous PET/MRI for the evaluation of neuroendocrine tumors in human subjects. Exclusion criteria included studies lacking simultaneous PET/MRI, absence of other than attenuation-correction MRI pulse sequences, and case reports. No data-pooling or statistical analysis was performed due to the small number of articles and heterogeneity of the methodologies. RESULTS: From the 21 identified articles, five were included, which demonstrated successful technical feasibility of simultaneous PET/MRI through various imaging protocols in a total of 105 patients. All articles demonstrated equal or superior detection of liver lesions by PET/MRI over PET/CT. While one study reported superior detection of bone lesions by PET/MRI, two demonstrated favorable detection by PET/CT. Two studies demonstrated superiority of PET/CT in detection of nodal metastases; three studies reported the pitfall of PET/MRI in detection of lung lesion. CONCLUSION: The current literature reports successful technical feasibility of PET/MRI for imaging of NETs. While whole-body PET/CT in conjunction with an abdominal MRI may serve as a comprehensive approach for baseline staging, follow up with PET/MRI may be preferred for those with liver-only disease. Another possible role for PET/MRI is to provide a multiparametric approach to follow up of response to treatment. With further advances in MRI imaging acquisitions and post-processing techniques, PET/MRI may become more applicable to a broader group of patients with NETs, and possibly the imaging modality of choice for this patient population.

Schlagwörter

Stichwörter der Autor:innen

Computed TomographyMagnetic Resonance ImagingNeuroendocrine TumorsPositron Emission Tomography

Autor:innen und Institutionen

  • Department of Radiology, University of Wisconsin-Madison, 600 Highland Ave, E1/382C, Madison, WI 53792.
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065.
  • Department of Nuclear Medicine, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185, Rome, Italy.

Förderung

  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Pirasteh, A., Riedl, C., Mayerhoefer, M. E., Giancipoli, R. G., Larson, S. M., & Bodei, L. (2019). PET/MRI for neuroendocrine tumors: a match made in heaven or just another hype?. Clinical and Translational Imaging, 7(6), 405-413. https://doi.org/10.1007/s40336-019-00344-1

Vancouver

Pirasteh A, Riedl C, Mayerhoefer ME, Giancipoli RG, Larson SM, Bodei L. PET/MRI for neuroendocrine tumors: a match made in heaven or just another hype?. Clinical and Translational Imaging. 2019;7(6):405-413. doi:10.1007/s40336-019-00344-1

BibTeX
@article{Pirasteh2019,
  author = {Pirasteh, Ali and Riedl, Christopher and Mayerhoefer, Marius Erik and Giancipoli, Romina Grazia and Larson, Steven Mark and Bodei, Lisa},
  title = {PET/MRI for neuroendocrine tumors: a match made in heaven or just another hype?},
  journal = {Clinical and Translational Imaging},
  year = {2019},
  volume = {7},
  number = {6},
  pages = {405--413},
  doi = {10.1007/s40336-019-00344-1}
}
Kostenlos starten →